Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 7/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.40 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.40 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.40 |
| ▸ | SCN1A | P35498 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20482006 | 0.98 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL20481943 | 0.98 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL20478154 | 0.98 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL28551387 | 0.91 | ALDH1A1 (0.45) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL739158 | 0.90 | TSHR (0.52) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL21066726 | 0.89 | TSHR (0.42) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL21066703 | 0.89 | TSHR (0.42) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL28537032 | 0.89 | HSD17B10 (0.56) | ALDH1A1LMNATSHRTDP1HTT | |
| SCHEMBL27770565 | 0.85 | TSHR (0.47) | ALDH1A1LMNATSHRTDP1UTS2R | |
| SCHEMBL2778 | 0.83 | TSHR (0.52) | ALDH1A1LMNATSHRTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4182737-B1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2024-07-03 | — | — | EP | disclosed |
| US-20230273456-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| EP-4182737-A1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2023-05-24 | — | — | EP | disclosed |
| EP-4182736-A1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2023-05-24 | — | — | EP | disclosed |
| EP-3514822-B1 | METHOD FOR MANUFACTURING FIELD EFFECT TRANSISTOR AND METHOD FOR MANUFACTURING WIRELESS COMMUNICATION DEVICE | TORAY INDUSTRIES (JP) | 2023-04-26 | — | — | EP | disclosed |
| EP-3868846-B1 | DECORATIVE AND PROTECTIVE COATING COMPOSITION FOR METAL, GLASS AND PLASTIC SUBSTRATES | EPG F (FR) | 2022-11-02 | — | — | EP | disclosed |
| WO-2022168613-A1 | NOVEL ORGANIC TITANIUM COMPOUND AND CURING CATALYST | 信越化学工業株式会社 | 2022-08-11 | — | — | WO | disclosed |
| US-11407903-B2 | Alkali-resistant coating for lightweight metals, in particular aluminum | EPG (ENGINEERED NANOPRODUCTS GERMANY) AG (DE) | 2022-08-09 | — | — | US | disclosed |
| CN-109476988-B | Composition for organic photoelectric device, and display device | 三星SDI株式会社 | 2022-05-10 | — | — | CN | disclosed |
| US-5434157-A | Active against herpes, hepatitis, papovavirus | THE UPJOHN COMPANY (US) | 1995-07-18 | — | — | US | disclosed |
| US-5002951-A | 2-amino-5-halo-4-pyrimidinol for bactericides and antiprotozoa agent | THE UPJOHN COMPANY (US) | 1991-03-26 | — | — | US | disclosed |
| US-4843080-A | VASODILATION; CARDIOVASCULAR ACTIVITY; CHEMICAL INTERMEDIATES | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1989-06-27 | — | — | US | disclosed |
| US-4665077-A | IMMUNOREGULATORY AGENTS | THE UPJOHN COMPANY (US) | 1987-05-12 | — | — | US | disclosed |
| EP-0202774-A2 | 1,12b-Disubstituted octahydroindolo [2,3-a]-Quinolizine derivatives | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1986-11-26 | — | — | EP | disclosed |
| US-4619933-A | 6-aryl pyrimidines for treating aplastic anemia | THE UPJOHN COMPANY (US) | 1986-10-28 | — | — | US | disclosed |
| US-4543248-A | Method for immunoregulation with 6-aryl pyrimidine compounds | THE UPJOHN COMPANY (US) | 1985-09-24 | — | — | US | disclosed |
| US-4507302-A | Method for treating arthritis with 6-aryl pyrimidine compounds | THE UPJOHN COMPANY (US) | 1985-03-26 | — | — | US | disclosed |
| US-4176196-A | Hypoglycemic arylcyclohexane acetic acids | PFIZER INC. (US) | 1979-11-27 | — | — | US | disclosed |
| US-4152230-A | PHOTOOXIDATION PROCESS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230273456-A1 | OPTICALLY ACTIVE DEVICES | PDE6C, PDE6D, PDE6A | ALDH1A1 277/4885LMNA 1560/4885TSHR 4585/4885 |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | PDE6C, PDE6A, PDE6D | ALDH1A1 311/4885LMNA 1559/4885TSHR 4592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.